Why Testing ROI & Patient Access Aren’t Mutually Exclusive
Genapsys CEO Jason Myers explains how his company is planning to solve return on investment and patient access with the company’s NGS platform.
Read MorePosted by Chris Wolski | Dec 20, 2021 | Sequencing Systems |
Genapsys CEO Jason Myers explains how his company is planning to solve return on investment and patient access with the company’s NGS platform.
Read MorePosted by Andy Lundin | Dec 20, 2021 | Diagnostic Technologies, Molecular Diagnostic Analyzers |
BD has expanded its BD COR System to include a new MX instrument for high-throughput molecular testing for infectious diseases.
Read MorePosted by Andy Lundin | Dec 17, 2021 | Sequencing Systems |
Singular Genomics Systems launched its G4 benchtop sequencer for commercial use in a range of applications, such as research in oncology and immunology.
Read MorePosted by Chris Wolski | Dec 9, 2021 | Diagnostic Technologies |
Industry experts predict a year of change and transformation ahead as the COVID-19 pandemic continues to influence the way clinical labs operate.
Read MorePosted by Andy Lundin | Dec 9, 2021 | Covid 19, Immunoassay Reagents & test Kits |
A new SARS-CoV-2 rapid antigen test is able to produces results in minutes, without the need for additional equipment or specially-trained personnel.
Read More